Demographics (3)
- AGE - Subject age at enrollment (phv00556780.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00556791.v1.p1)
- SEX - Biological sex (phv00556772.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00556779.v1.p1)
Other (16)
- AGE_ONSET - Disease onset age (phv00556781.v1.p1)
- ANALYTE_ANALYSIS_TYPE - Analysis of Analyte Type (phv00556785.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00556784.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00556783.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00556771.v1.p1)
- DISEASE_TYPE - Disease Type (phv00556787.v1.p1)
- DISEASE_TYPE - Disease Type (phv00556778.v1.p1)
- DOSAGE_TREATMENT - Dosage of Treatment (phv00556789.v1.p1)
- SAMPLE_ID - Sample ID (phv00556782.v1.p1)
- SAMPLE_ID - Sample ID (phv00556776.v1.p1)
- SUBJECT_ID - Subject ID (phv00556777.v1.p1)
- SUBJECT_ID - Subject ID (phv00556770.v1.p1)
- SUBJECT_ID - Subject ID (phv00556775.v1.p1)
- TREATMENT_FREQUENCY - Frequency of Treatment (phv00556790.v1.p1)
- TREATMENT_TIMEPOINT - Timepoint post-initiation of treatment (phv00556788.v1.p1)
- TREATMENT_TYPE - Treatment Type (phv00556786.v1.p1)